| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.08B | 91.92B | 90.45B | 87.03B | 85.10B | 78.34B |
| Gross Profit | 31.38B | 30.16B | 27.55B | 28.96B | 29.52B | 25.95B |
| EBITDA | 7.47B | 6.24B | 4.50B | 6.25B | 7.58B | 5.83B |
| Net Income | 4.91B | 2.50B | -885.00M | 1.35B | 2.67B | -931.00M |
Balance Sheet | ||||||
| Total Assets | 127.11B | 128.54B | 123.22B | 122.31B | 123.79B | 119.08B |
| Cash, Cash Equivalents and Short-Term Investments | 30.29B | 27.08B | 25.55B | 24.46B | 28.30B | 27.98B |
| Total Debt | 15.09B | 15.25B | 14.12B | 12.19B | 12.52B | 11.91B |
| Total Liabilities | 46.76B | 50.31B | 47.07B | 49.86B | 53.29B | 49.38B |
| Stockholders Equity | 78.69B | 76.56B | 73.03B | 69.27B | 66.98B | 66.04B |
Cash Flow | ||||||
| Free Cash Flow | -1.39B | 732.00M | 2.19B | -1.03B | 963.00M | -164.00M |
| Operating Cash Flow | 367.50M | 5.30B | 5.66B | 2.95B | 4.69B | 5.95B |
| Investing Cash Flow | -2.29B | -3.81B | -5.66B | -5.02B | -4.27B | -10.26B |
| Financing Cash Flow | 404.50M | 275.00M | 1.15B | -1.64B | 539.00M | 4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥35.82B | 6.07 | ― | 1.67% | 7.33% | ― | |
70 Outperform | ¥928.30B | 21.98 | 5.45% | 1.30% | 4.55% | -7.49% | |
69 Neutral | ¥803.90B | 11.82 | 6.38% | 1.03% | 7.90% | 54.01% | |
69 Neutral | ¥112.25B | 10.12 | ― | 1.71% | 7.01% | 72.94% | |
64 Neutral | ¥347.73B | 6.57 | 7.48% | 1.79% | 6.63% | 80.44% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | ¥624.44B | 25.92 | -2.45% | 1.40% | -6.29% | -141.32% |